share_log

HC Wainwright & Co. Reiterates Buy on Elevation Oncology, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Elevation Oncology, Maintains $6 Price Target

HC Wainwright & Co.重申买入Elevation Oncology,维持6美元的目标股价
Moomoo 24/7 ·  03/07 07:40

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains $6 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth重申了Elevation Oncology(纳斯达克股票代码:ELEV)的买入并维持6美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发